Status:
UNKNOWN
Lifestyle Medicine for Depression 2019
Lead Sponsor:
Chinese University of Hong Kong
Collaborating Sponsors:
University of Melbourne
University of Western Sydney
Conditions:
Depression
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This study will examine the feasibility and efficacy of lifestyle medicine for the enhancement of psychological wellness in adult. The main components of lifestyle intervention typically include physi...
Eligibility Criteria
Inclusion
- Hong Kong residents aged ≥ 18 years;
- Cantonese language fluency;
- Patient Health Questionnaire (PHQ-9) score ≥ 10; and
- Willingness to provide informed consent and comply with the trial protocol
Exclusion
- Pregnancy;
- Have suicidal ideation with PHQ-9 item 9 score ≥ 2 (referral information to professional services will be provided to those who endorsed items on suicidal ideation);
- Using medication or psychotherapy for depression;
- Having unsafe conditions and are not recommended for physical activity or a change in diet by physicians; and
- Have major psychiatric, medical or neurocognitive disorders that make participation infeasible or interfere with the adherence to the lifestyle intervention
Key Trial Info
Start Date :
November 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04070417
Start Date
November 1 2019
End Date
August 1 2020
Last Update
January 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Chinese University of Hong Kong
Hong Kong, Hong Kong